步长制药(603858.SH)拟注销控股子公司步长医学诊断

Core Viewpoint - The company has decided to optimize resource allocation and reduce management costs by proposing the cancellation of its subsidiary, Step Long (Guangzhou) Medical Diagnostic Technology Co., Ltd. [1] Group 1 - The fifth session of the company's board of directors held on September 4, 2025, approved the proposal to cancel Step Long (Guangzhou) Medical Diagnostic Technology Co., Ltd. [1] - The decision is part of a broader strategy to enhance operational efficiency within the company [1]